Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4641457
Max Phase: Preclinical
Molecular Formula: C39H69N11O9
Molecular Weight: 836.05
Molecule Type: Unknown
Associated Items:
ID: ALA4641457
Max Phase: Preclinical
Molecular Formula: C39H69N11O9
Molecular Weight: 836.05
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(C)C[C@H](NC(=O)CCC1CCCCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(N)=O
Standard InChI: InChI=1S/C39H69N11O9/c1-22(2)18-27(45-32(53)15-14-24-10-6-5-7-11-24)35(56)48-28(19-23(3)4)36(57)49-29(21-51)38(59)50-17-9-13-30(50)37(58)46-25(12-8-16-44-39(42)43)34(55)47-26(33(41)54)20-31(40)52/h22-30,51H,5-21H2,1-4H3,(H2,40,52)(H2,41,54)(H,45,53)(H,46,58)(H,47,55)(H,48,56)(H,49,57)(H4,42,43,44)/t25-,26-,27-,28-,29-,30-/m0/s1
Standard InChI Key: OGDBADAYLBBJJX-WPMUBMLPSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 836.05 | Molecular Weight (Monoisotopic): 835.5280 | AlogP: -1.53 | #Rotatable Bonds: 25 |
Polar Surface Area: 334.12 | Molecular Species: BASE | HBA: 10 | HBD: 11 |
#RO5 Violations: 2 | HBA (Lipinski): 20 | HBD (Lipinski): 14 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.87 | CX Basic pKa: 12.18 | CX LogP: -2.86 | CX LogD: -4.54 |
Aromatic Rings: 0 | Heavy Atoms: 59 | QED Weighted: 0.03 | Np Likeness Score: -0.03 |
1. Takayama K, Mori K, Tanaka A, Sasaki Y, Sohma Y, Taguchi A, Taniguchi A, Sakane T, Yamamoto A, Miyazato M, Minamino N, Kangawa K, Hayashi Y.. (2020) A chemically stable peptide agonist to neuromedin U receptor type 2., 28 (10): [PMID:32247748] [10.1016/j.bmc.2020.115454] |
Source(1):